Integra LifeSciences

Integra LifeSciences to acquire the Codman Neurosurgery Business for $1.04B in Cash

Thursday, February 16, 2017

Integra LifeSciences, a global provider of medical technology, has made a binding offer to acquire the Johnson & Johnson Codman Neurosurgery business for a price of $1.045 billion in cash. Codman Neurosurgery offers a portfolio of devices focused on advanced hydrocephalus, neuro-critical care and operative neurosurgery. If the binding offer is accepted, upon closing, Integra will be a global provider of neurosurgical products.

[Read More]